Creative Planning

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1540235 OVERLAND PARK, KS

Position in RIGL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$885,558

+$514,299 QoQ

Shares Held

22,637

+64.9% QoQ

Ownership

0.121%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 156 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. RIGL ranks #89 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$885,558	22,637	+64.9%	Shares	Defined	2026-08-13
2026-03-31	$371,259	13,730	+31.6%	Shares	Sole	2026-05-12
2025-12-31	$446,759	10,431	+23.1%	Shares	Sole	2026-02-17
2025-09-30	$240,096	8,475	-45.6%	Shares	Sole	2025-11-14
2025-03-31	$280,482	15,591	+29317.0%	Shares	Sole	2025-05-15
2024-12-31	$891	53	-99.5%	Shares	Defined	2025-02-14
2023-09-30	$12,693	11,753	+17.5%	Shares	Sole	2023-11-16
2021-09-30	$36,300	10,000	0.0%	Shares	Sole	2021-11-10
2021-06-30	$43,400	10,000	-50.5%	Shares	Sole	2021-08-04
2021-03-31	$69,084	20,200	+98.0%	Shares	Sole	2021-04-30
2020-12-31	$35,700	10,200	-49.5%	Shares	Sole	2021-01-29
2020-09-30	$48,480	20,200	0.0%	Shares	Sole	2020-11-05
2020-06-30	$36,966	20,200	+1.0%	Shares	Sole	2020-07-23
2020-03-31	$31,200	20,000	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.